We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRAY icon
351
Dentsply Sirona
XRAY
$2.75B
$4.63M 0.03%
89,351
-27,602
-24% -$943K
NET icon
352
Cloudflare
NET
$101B
$4.63M 0.03%
47,820
+6,475
+16% +$586K
CARR icon
353
Carrier Global
CARR
$50.6B
$4.49M 0.03%
77,311
-1,057
-1% -$59.4K
PXD
354
DELISTED
Pioneer Natural Resource Co.
PXD
$4.46M 0.03%
16,986
+3,323
+24% +$779K
RCKT icon
355
Rocket Pharmaceuticals
RCKT
$351M
$4.45M 0.03%
165,000
+55,000
+50% +$1.56M
EXC icon
356
Exelon
EXC
$46.6B
$4.44M 0.03%
118,097
-394,539
-77% -$14.1M
SWKS icon
357
Skyworks Solutions
SWKS
$9.4B
$4.34M 0.03%
40,098
+11,280
+39% +$1.18M
HIG icon
358
Hartford Financial Services
HIG
$39.2B
$4.31M 0.03%
41,870
+2,506
+6% +$230K
RGA icon
359
Reinsurance Group of America
RGA
$15.6B
$4.31M 0.03%
+22,328
New +$3.9M
SHLS icon
360
Shoals Technologies Group
SHLS
$1.49B
$4.27M 0.03%
381,988
– –
PHR icon
361
Phreesia
PHR
$656M
$4.26M 0.03%
177,939
-185,501
-51% -$4.61M
FAST icon
362
Fastenal
FAST
$53.5B
$4.22M 0.03%
109,536
+9,820
+10% +$347K
RLAY icon
363
Relay Therapeutics
RLAY
$4.24B
$4.22M 0.03%
508,429
-212,641
-29% -$2.07M
BCO icon
364
Brink's
BCO
$4.84B
$4.22M 0.03%
45,654
+31,091
+213% +$2.58M
TFC icon
365
Truist Financial
TFC
$63.5B
$4.2M 0.03%
107,636
+1,394
+1% +$51K
WST icon
366
West Pharmaceutical
WST
$23.9B
$4.18M 0.03%
10,568
+5,167
+96% +$1.91M
SAGE
367
DELISTED
Sage Therapeutics
SAGE
$4.16M 0.03%
222,000
-5,000
-2% -$115K
KALV
368
DELISTED
KalVista Pharmaceuticals
KALV
$4.15M 0.03%
+350,000
New +$4.67M
SONY icon
369
Sony
SONY
$134B
$4.13M 0.03%
240,835
+68,490
+40% +$1.26M
CRNX icon
370
Crinetics Pharmaceuticals
CRNX
$8.85B
$4.12M 0.03%
88,005
-200,006
-69% -$7.83M
VERV
371
DELISTED
Verve Therapeutics
VERV
$4.12M 0.03%
310,000
– –
KDP icon
372
Keurig Dr Pepper
KDP
$43B
$4.1M 0.03%
133,538
+26,046
+24% +$802K
EOG icon
373
EOG Resources
EOG
$77.5B
$4.07M 0.03%
31,814
-3,781
-11% -$441K
RUN icon
374
Sunrun
RUN
$2.27B
$4.04M 0.03%
306,528
– –
LYV icon
375
Live Nation Entertainment
LYV
$42.7B
$4.04M 0.03%
38,189
+5,423
+17% +$513K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.